• α-Bungarotoxin for Nicotinic Receptor Blockade

  2026-08-24

  α-Bungarotoxin turns α7 nicotinic acetylcholine receptor involvement into a testable variable across neuronal, neuromuscular, and placental assays. This practical guide covers receptor-blockade design, concentration planning, pathway-level controls, and troubleshooting for cholinergic signaling and necroptosis studies.

• Rotavirus Infection Suppresses Nrf2 Redox Defense

  2026-08-24

  This study shows that rotavirus infection produces a biphasic Nrf2 response: an early, redox-sensitive increase is followed by progressive Nrf2 depletion, nuclear loss, and suppression of antioxidant gene expression. Its mechanistic analysis implicates proteasome-associated, K48-linked ubiquitination rather than canonical Keap1/Cul3-Rbx1 turnover as a major contributor to late Nrf2 loss, providing a framework for studying virus-induced disruption of cellular stress adaptation.

• Methoxy-X04 Maps Exercise-Driven Aβ Clearance

  2026-08-23

  Methoxy-X04 is a fluorescent amyloid beta probe for connecting plaque burden with microglial clearance mechanisms in Alzheimer’s disease models. This article develops an assay strategy inspired by exercise-induced skeletal muscle extracellular vesicles, emphasizing interpretation, controls, and biological meaning rather than routine imaging alone.

• Nullscript: Epigenetic Leverage for Translational Research

  2026-08-22

  Nullscript illustrates why HDAC inhibitor research should separate enzyme inhibition from downstream transcriptional behavior. This thought-leadership guide connects its mechanistic profile and cardioprotective preclinical signal with a disciplined validation strategy, while using recent necroptosis research to define—not overstate—opportunities for translational investigation.

• Temafloxacin Combinations Against M. avium

  2026-08-22

  This 1993 study evaluated clarithromycin, temafloxacin, and ethambutol against pigmented and non-pigmented Mycobacterium avium complex isolates using MIC, fractional inhibitory concentration, and macrophage models. Its central contribution was to show that combination activity was strain dependent in agar assays, while the three-drug combination produced the strongest intracellular bactericidal effect.

• JNJ-10198409 PDGF Receptor Assay Guide

  2026-08-21

  This scenario-based guide shows how JNJ-10198409, SKU C5737, can support reproducible PDGF-BB receptor inhibition studies across viability, proliferation, and cytotoxicity assays. It covers dose selection, solvent compatibility, protocol optimization, data interpretation, and practical vendor evaluation using the compound’s documented potency and formulation data.

• MCC950 sodium in Endotoxemia Assays

  2026-08-20

  MCC950 sodium enables selective interrogation of NLRP3 signaling while separating inflammasome-driven IL-1β release from TLR4-dominant coagulation responses. This workflow translates endotoxemia findings into practical macrophage, extracellular-vesicle, and autoimmune disease experiments.

• APEX2 Supports TERT Expression in Human Stem Cells

  2026-08-20

  A 2024 bioRxiv preprint identifies APEX2, but not its paralog APEX1, as a factor required for efficient TERT expression and telomerase activity in human embryonic stem cells. RNA-seq and chromatin immunoprecipitation link this function to APEX2 occupancy near MIR repetitive elements within TERT intron 2, suggesting that DNA repair at repetitive sequences can influence gene expression.

• 17-AAG and Assay Logic: HSP90 to NINJ1

  2026-08-19

  17-AAG (Tanespimycin) is a powerful probe for HSP90-dependent oncogenic signaling, but its effects must be separated from downstream cell death and protein-release events. This article develops an assay framework connecting HSP90 client-protein degradation with insights from the NINJ1-mediated norovirus secretion study.

• Pitavastatin (NK-104): In Vitro Workflow Guide

  2026-08-19

  Pitavastatin (NK-104, SKU B1124) provides a defined HMG-CoA reductase inhibitor for controlled studies of cholesterol biosynthesis, with a dossier-reported HepG2 reference IC50 of 5.8 nM. This guide covers preparation, assay controls, and QC for in vitro work; it does not establish clinical, animal, or directly paper-matched applications.

• APEX2 Promotes TERT Expression in Human Stem Cells

  2026-08-18

  This study identifies APEX2 as a DNA repair factor required for efficient TERT expression in human embryonic stem cells and melanoma cells, distinguishing its function from the related enzyme APEX1. RNA-seq and chromatin immunoprecipitation connect APEX2-dependent transcription to repetitive DNA, especially MIR elements within TERT intron 2, suggesting that repair of damage-prone sequences can influence telomerase regulation.

• WM-8014: KAT6A Inhibitor Guide

  2026-08-18

  WM-8014 is a reversible, competitive KAT6A inhibitor with activity against KAT6B, KAT5, and KAT7. It supports mechanistic studies of histone acetyltransferase inhibition, oncogene-induced senescence induction, and cancer biology research.

• AM251 Workflows for CB1 Receptor Research

  2026-08-17

  AM251 is a practical pharmacological switch for separating CB1-dependent signaling from broader endocannabinoid effects in neural, metabolic, and cell-based models. This workflow-focused guide connects receptor blockade with pain, appetite, cAMP, apoptosis, and behavioral readouts while emphasizing solvent control and interpretation limits.

• Phenytoin for Myelin and Sodium Channel Assays

  2026-08-17

  Phenytoin provides a practical chemical perturbation for linking voltage-gated sodium channel activity with dynamic myelin damage. This guide translates recent live-imaging findings into reproducible electrophysiology, organotypic-slice, and neurological disease model workflows, with formulation and troubleshooting advice.

• Rapamycin (Sirolimus): mTOR Research Guide

  2026-08-16

  Rapamycin, also called Sirolimus, is an FKBP12-dependent mTOR inhibitor used to study cell growth, immune activation, cancer metabolism, and mitochondrial disease. Its reported mTOR IC50 is approximately 0.1 nM, but assay conditions, exposure duration, and cell context determine experimental response.

8458 records 1/564 page Next 12345 下5页 Last page